
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+3
YUMAB Company profile The German biotech company YUMAB was founded in 2012 as spin-off the University of Braunschweig. In little more than five years, YUMAB (a phonetic play on HUMAB, which stands for human monoclonal antibody and in which the Y symbolizes the well-known antibody structure) has become a global player in human monoclonal antibody (mAb) development, and drives the general trend in the immunotherapy space toward the use of fully human mAbs for therapeutic applications. The YUMAB antibody platform provides rapid, reliable and robust development of state-of-the-art and next-generation fully human antibodies. The technologies base on more than 28...
Therapeutic antibodies,phage display,monoclonal antibodies,library generation,fully human antibody discovery,antibody optimization,antibody affinity maturation,and various antibody formats
Yumab gmbh operates in the Biotechnology research industry.
Yumab gmbh's revenue is 11m - 100m
Yumab gmbh has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.